<

 
Data updated 2025-05-07 00:05:00
Translation DK > English
Need help for the searches?
[DISPLAY PATENT]
 
Choose application no.
 
Application no. and date00926404.5 (espacenet)  (Federated)  (European Patent Register), 20000427
Patent/reg. no. and dateDK/EP 1173197, 20041201
Publication date20020123
Priority no. and dateUS 302596, 19990430
EP pub. no. and date EP 1173197 20020123
Effective date
Applicant/ownerAmylin Pharmaceuticals, LLC, 9360 Towne Centre Drive
San Diego, CA 92121, US,
AstraZeneca Pharmaceuticals LP, 1800 Concord Pike
Wilmington, DE 19850-5437, US
Applicant ref. no.P38333 DK 01
InventorCOOLIDGE, Thomas, R., 3820 N.W. 46th Street
Lincoln, NE 68524, US,
EHLERS, Mario, R., W., 3820 N.W. 46th Street
Lincoln, NE 68524, US
RepresentativePlougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK
Opponent
IPC ClassA61K 38/26 (2006.01) , A61P 9/10 (2006.01) , A61K 31/7004 (2006.01) , A61K 31/7004 (2006.01) , A61K 33/00 (2006.01) , A61K 38/06 (2006.01) , A61K 38/26 (2006.01) , A61K 38/26 (2006.01) , A61K 38/26 (2006.01) , A61K 38/26 (2006.01) , A61K 38/44 (2006.01) 
TitleMetabolisk intervention med GLP-1 til forbedring af iskæmisk og reperfunderet vævs funktion
Int. application no.US2000011251
Int. publication no.WO2000066138
Related patent (certificate)
StatusBortfaldet
Pædiatrisk forlængelse-
Udløbsdato for pædiatrisk forlængelse-

 
Home | Danish Patent and Trademark Office, Helgeshøj Allé 81, 2630 Tåstrup, Denmark Tel.: +45 4350 8000, email | Contact